Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1975 Jul;80(1):69–78.

Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cells.

P E Bigazzi, T Yoshida, P A Ward, S Cohen
PMCID: PMC1912835  PMID: 168779

Abstract

Macrophage migration inhibitory (MIF-like) activity was demonstrated in the supernatant fluids from primary cultures of African green monkey kidney cells infected with simian virus 40 (SV 40) virus. Kidney cell cultures not infected by virus had no MIF activity. Supernatant fluids from continuous cultures of nontransformed and SV 40-transformed human fibroblasts contained MIF-like activity. Productive infection with SV 40 virus results in the production of a lymphokine-like factor, as previously observed in other virus-cell systems, involving mumps virus and Newcast,le disease virus. However, while infection with these paramyxoviruses causes the production of macrophage and neutrophil chemotactic agents as well as an MIF, SV 40 infection does not induce chemotactic factors. The results reported here, taken in conjunction with previous observations by ourselves and others, suggest that the production of lymphokine-like factors (cytokines) may represent a general biologic phenomenon, and that many, if not all, cell types, when appropriately stimulated, may be capable of such activity.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acton J. D. The lymphoreticular system and interferon production. J Reticuloendothel Soc. 1973 Nov;14(5):449–461. [PubMed] [Google Scholar]
  2. Borecký L., Fuchsberger N., Hájnická V., Stancek D., Zemla J. Distribution of antiviral and cell-inhibitory activity in interferon preparations. Acta Virol. 1972 Jul;16(4):356–358. [PubMed] [Google Scholar]
  3. Braun W., Levy H. B. Interferon preparations as modifiers of immune responses. Proc Soc Exp Biol Med. 1972 Dec;141(3):769–773. doi: 10.3181/00379727-141-36868. [DOI] [PubMed] [Google Scholar]
  4. Cohen S., Bigazzi P. E., Yoshida T. Commentary. Similarities of T cell function in cell-mediated immunity and antibody production. Cell Immunol. 1974 Apr;12(1):150–159. doi: 10.1016/0008-8749(74)90066-5. [DOI] [PubMed] [Google Scholar]
  5. DIDERHOLM H. PRODUCTION OF INTERFERON BY MONKEY KIDNEY CELLS INFECTED WITH SIMIAN VIRUS 40. Arch Gesamte Virusforsch. 1963 Oct 7;14:39–44. doi: 10.1007/BF01555161. [DOI] [PubMed] [Google Scholar]
  6. Flanagan T. D., Yoshida T., Cohen S. Production of macrophage migration inhibition factors by virus-infected cell cultures. Infect Immun. 1973 Aug;8(2):145–150. doi: 10.1128/iai.8.2.145-150.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gaffney E. V., Picciano P. T., Grant C. A. Inhibition of growth and transformation of human cells by interferon. J Natl Cancer Inst. 1973 Apr;50(4):871–878. doi: 10.1093/jnci/50.4.871. [DOI] [PubMed] [Google Scholar]
  8. Gresser I., Bourali-Maury C. The antitumor effect of interferon in lymphocyte- and macrophage-depressed mice. Proc Soc Exp Biol Med. 1973 Dec;144(3):896–900. doi: 10.3181/00379727-144-37706. [DOI] [PubMed] [Google Scholar]
  9. Grossberg S. E. The interferons and their inducers: molecular and therapeutic considerations. 3. N Engl J Med. 1972 Jul 20;287(3):122–128. doi: 10.1056/NEJM197207202870305. [DOI] [PubMed] [Google Scholar]
  10. Hammond M. E., Roblin R. O., Dvorak A. M., Selvaggio S. S., Black P. H., Dvorak H. F. MIF-like activity in simian virus 40-transformed 3T3 fibroblast cultures. Science. 1974 Sep 13;185(4155):955–957. doi: 10.1126/science.185.4155.955. [DOI] [PubMed] [Google Scholar]
  11. Hill J. H., Ward P. A. C3 leukotactic factors produced by a tissue protease. J Exp Med. 1969 Sep 1;130(3):505–518. doi: 10.1084/jem.130.3.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Huang K. Y., Donahoe R. M., Gordon F. B., Dressler H. R. Enhancement of phagocytosis by interferon-containing preparations. Infect Immun. 1971 Nov;4(5):581–588. doi: 10.1128/iai.4.5.581-588.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lindahl P., Leary P., Gresser I. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A. 1972 Mar;69(3):721–725. doi: 10.1073/pnas.69.3.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Martin M. A., Gelb L. D., Garon C., Takemoto K. K., Lee T. N., Sack G. H., Jr, Nathans D. Characterization of "heavy" and "light" SV40-like particles from a patient with PML. Virology. 1974 May;59(1):179–189. doi: 10.1016/0042-6822(74)90214-1. [DOI] [PubMed] [Google Scholar]
  15. Mullarkey M. F., Hruska J. F., Takemoto K. K. Comparison of two human papovaviruses with simian virus 40 by structural protein and antigenic analysis. J Virol. 1974 May;13(5):1014–1019. doi: 10.1128/jvi.13.5.1014-1019.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Oxman M. N., Levin M. J. Interferon and transcription of early virus-specific RNA in cells infected with simian virus 40. Proc Natl Acad Sci U S A. 1971 Feb;68(2):299–302. doi: 10.1073/pnas.68.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. PLUMMER G. Interfering properties of simian viruses. Br J Exp Pathol. 1963 Feb;44:58–65. [PMC free article] [PubMed] [Google Scholar]
  18. Papageorgiou P. S., Henley W. L., Glade P. R. Production and characterization of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines. J Immunol. 1972 Feb;108(2):494–504. [PubMed] [Google Scholar]
  19. Todaro G. J., Baron S. The role of interferon in the inhibition of SV40 transformation of mouse cell line 3T3. Proc Natl Acad Sci U S A. 1965 Sep;54(3):752–756. doi: 10.1073/pnas.54.3.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tubergen D. G., Feldman J. D., Pollock E. M., Lerner R. A. Production of macrophage migration inhibition factor by continuous cell lines. J Exp Med. 1972 Feb 1;135(2):255–266. doi: 10.1084/jem.135.2.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ward P. A. Chemotoxis of mononuclear cells. J Exp Med. 1968 Nov 1;128(5):1201–1221. doi: 10.1084/jem.128.5.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ward P. A., Cochrane C. G., Muller-Eberhard H. J. Further studies on the chemotactic factor of complement and its formation in vivo. Immunology. 1966 Aug;11(2):141–153. [PMC free article] [PubMed] [Google Scholar]
  23. Ward P. A., Cohen S., Flanagan T. D. Leukotactic factors elaborated by virus-infected tissues. J Exp Med. 1972 May 1;135(5):1095–1103. doi: 10.1084/jem.135.5.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weiner L. P., Herndon R. M., Narayan O., Johnson R. T., Shah K., Rubinstein L. J., Preziosi T. J., Conley F. K. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med. 1972 Feb 24;286(8):385–390. doi: 10.1056/NEJM197202242860801. [DOI] [PubMed] [Google Scholar]
  25. Yoshida T., Bigazzi P. E., Cohen S. The production of anti-guinea pig lymphokine antibody. J Immunol. 1975 Feb;114(2 Pt 1):688–691. [PubMed] [Google Scholar]
  26. Yoshida T., Janeway C. A., Jr, Paul W. E. Activity of migration inhibitory factor in the absence of antigen. J Immunol. 1972 Aug;109(2):201–206. [PubMed] [Google Scholar]
  27. Yoshida T., Sonozaki H., Cohen S. The production of migration inhibition factor by B and T cells of the guinea pig. J Exp Med. 1973 Oct 1;138(4):784–797. doi: 10.1084/jem.138.4.784. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES